Product NDC: | 0046-0749 |
Proprietary Name: | Premarin |
Non Proprietary Name: | conjugated estrogens |
Active Ingredient(s): | 25 mg/5mL & nbsp; conjugated estrogens |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0046-0749 |
Labeler Name: | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA010402 |
Marketing Category: | NDA |
Start Marketing Date: | 19561201 |
Package NDC: | 0046-0749-05 |
Package Description: | 1 VIAL in 1 CARTON (0046-0749-05) > 25 mL in 1 VIAL |
NDC Code | 0046-0749-05 |
Proprietary Name | Premarin |
Package Description | 1 VIAL in 1 CARTON (0046-0749-05) > 25 mL in 1 VIAL |
Product NDC | 0046-0749 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | conjugated estrogens |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19561201 |
Marketing Category Name | NDA |
Labeler Name | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
Substance Name | ESTROGENS, CONJUGATED |
Strength Number | 25 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Estrogen [EPC],Estrogen Receptor Agonists [MoA],Estrogens, Conjugated (USP) [Chemical/Ingredient] |